1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Medicina
  4. Articles publicats en revistes (Medicina)
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/132145
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHuang, David B.-
dc.contributor.authorDuncan, Leonard R.-
dc.contributor.authorFlamm, Robert K.-
dc.contributor.authorDryden, Matthew-
dc.contributor.authorCorey, G. Ralph-
dc.contributor.authorWilcox, Mark H.-
dc.contributor.authorTorres Martí, Antoni-
dc.contributor.authorFile, Thomas M.-
dc.date.accessioned2019-04-12T07:57:52Z-
dc.date.available2019-04-12T07:57:52Z-
dc.date.issued2018-01-
dc.identifier.issn0732-8893-
dc.identifier.urihttps://hdl.handle.net/2445/132145-
dc.description.abstractThe in vitro antimicrobial activity of iclaprim, a novel diaminopyrimidine, against common respiratory bacteria remained unchanged in the presence of pulmonary surfactant (Survanta®) at concentrations that greatly antagonized the antimicrobial activity of daptomycin. These results indicate that iclaprim could be a potential treatment for pneumonia caused by susceptible and multidrug resistant bacteria.-
dc.format.extent3 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.diagmicrobio.2017.09.011-
dc.relation.ispartofDiagnostic Microbiology and Infectious Disease, 2018, vol. 90, num. 1, p. 64-66-
dc.relation.urihttps://doi.org/10.1016/j.diagmicrobio.2017.09.011-
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationPneumònia-
dc.subject.classificationBacteris patògens-
dc.subject.classificationEfecte dels medicaments sobre els microorganismes-
dc.subject.otherPneumonia-
dc.subject.otherPathogenic bacteria-
dc.subject.otherEffect of drugs on microorganisms-
dc.titleThe effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec675127-
dc.date.updated2019-04-12T07:57:52Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
675127.pdf156.84 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons